Drug Trial Radar · NCT01925261
A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees
Last checked: Nov 19, 2026Latest source record: Apr 21, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Planned (sponsor's estimate)
Start
Jan 2014
Primary completion
Sep 2016
Study completion Sep 2016
Sponsor
- Lead sponsor
- OrthoTrophix, IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 19, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 25 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This one-year study is designed to investigate the safety and efficacy of TPX-100, a 23-amino acid chondrogenic peptide, delivered by intra-articular injection, in regeneration of knee cartilage in subjects with bilateral osteoarthritis of the knee.
Conditions
- Knee Osteoarthritis
Interventions
TPX-100 50mgDrug
TPX-100 100mgDrug
TPX-100 200mgDrug
TPX-100 20mgDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in cartilage thickness in the patello-femoral compartment as measured on standardized MRI from baseline to 12 monthsTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
C3 Clinical Research Associates
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.